CWRU, Cleveland Clinic collaborate with Microsoft on mixed-reality technology
Dr. Griswold told tens of thousands of people how HoloLens can transform learning across countless subjects, including those as complex as the human body. Speaking to an in-person and online audience at Microsoft’s annual Build conference, he highlighted disciplines as disparate as art history and engineering—but started with a holographic heart.
Dr. Alberto Costa has Personal Stake in Potential Down Syndrome Breakthrough Studies
Dr. Alberto Costa didn't start out as a Down syndrome researcher. But when his daughter was born with the condition in 1995, his career quickly changed course.
Today, Costa is overseeing studies that, if successful, could set the stage for new drug development in the next decade that improves memory and other cognitive function in adults with Down syndrome.
Drugs stimulate body’s stem cells to replace the brain cells lost in multiple sclerosis
A pair of topical medicines already alleviating skin conditions may prove to have another, even more compelling use: instructing stem cells in the brain to reverse damage caused by multiple sclerosis.
Strategic Plan 2013
The School of Medicine recently completed a 5-year strategic plan. Goals, strategies, and implementation plans have been finalized and integrated with the University Strategic Plan. Please visit the SOM Strategic Plan website and contact us if you have questions or ideas.